USPTO serial 99666553

EMBRYONEST

Status 641Office Action

Need help with EMBRYONEST?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Deadline: September 29th, 2026

Class	Description	Status	First use
001	Synthetic bioactive hydrogels for use in laboratory research and the optimization of embryo growth; hydrogel-based substrates for use in the screening and testing of embryo culture media and reagents in a laboratory setting; chemical preparations for use in the manufacture of embryo culturing surfaces.	ACTIVE	—
005	Medical preparations for use in assisted reproductive technology (ART) and in vitro fertilization (IVF), namely, bioactive hydrogels used as an embryo culture substrate to facilitate development and enhance embryo implantation competency; Clinical medical reagents for priming human embryos to increase clinical success rates in IVF procedures.	ACTIVE	—
010	Medical devices for use in in vitro fertilization (IVF) procedures, namely, embryo culture plates containing a bioactive hydrogel substrate; laboratory apparatus for clinical use, namely, specialized multi-well plates pre-treated with hydrogel for the nurturing and monitoring of human embryos.	ACTIVE	—

Date	Code	Event
Jun 29, 2026	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 29, 2026	GNRT	NON-FINAL ACTION E-MAILED
Jun 29, 2026	CNRT	NON-FINAL ACTION WRITTEN
Jun 22, 2026	DOCK	ASSIGNED TO EXAMINER
Jun 21, 2026	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2026	MAFR	APPLICATION FILING RECEIPT MAILED
Feb 23, 2026	NWAP	NEW APPLICATION ENTERED